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           Yeasts such as   Cryptococcus neoformans   and   Can-
dida albicans   are an emerging group of infectious 
pathogens in patients with impaired T cell  – 
mediated immunity, such as those with AIDS, 
solid organ transplant recipients, and hospital-
ized patients (  1, 2  ). Although much work has 
been devoted in the past decade to uncovering 
the role of pattern recognition receptors in the 
innate response to bacteria and viruses, our un-
derstanding of how the innate immune system 
senses fungal pathogens is less clear (  3  ). The 
macrophage, a central component of the innate 
immune system, is essential to the eff  ective 
immune response to pathogenic yeast. Macro-
phages have direct antimicrobial activity against 
these organisms; they promote antigen presen-
tation, polysaccharide sequestration, and cyto-
kine and che  mokine production (  4  –  6  ). There 
is also evidence that persistent infection is asso-
ciated with the intracellular residence of yeast 
cells in macrophages. Furthermore, infected cir-
culating macrophages can transfer these patho-
gens and cause dissemination of these infections 
hematogenously (  7  ). 
  Recently, the C-type lectin-like receptor 
Dectin-1 was shown to be a macrophage re-
ceptor for     -glucans and to bind several fungi 
(  8  –  12  ).     -glucan is a major carbohydrate found 
in the fungal cell wall. Dectin-1 mediates both 
Toll-like receptor (TLR) –  dependent and TLR-
independent responses to fungi in vitro. How-
ever, the role of Dectin-1 in the host response to 
fungal pathogens in vivo is less clear (  13  –  15  ), sug-
gesting that additional receptors contribute to the 
innate immune response to fungal pathogens. 
  Scavenger receptors constitute a diverse 
family of pattern recognition receptors that rec-
ognize both endogenous and pathogen-derived 
ligands. These receptors are expressed on cells 
patrolling potential portals of pathogen entry, 
including macrophages, dendritic cells, microglia, 
and endothelial cells, and are believed to be in-
volved in the pathogenesis of chronic infl  am-
matory conditions such as atherosclerosis and 
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  Receptors involved in innate immunity to fungal pathogens have not been fully elucidated. 
We show that the   Caenorhabditis elegans   receptors CED-1 and C03F11.3, and their mam-
malian orthologues, the scavenger receptors SCARF1 and CD36, mediate host defense 
against two prototypic fungal pathogens,   Cryptococcus neoformans   and   Candida albicans.   
CED-1 and C03F11.1 mediated antimicrobial peptide production and were necessary for 
nematode survival after   C. neoformans   infection. SCARF1 and CD36 mediated cytokine 
production and were required for macrophage binding to   C. neoformans  , and control of the 
infection in mice. Binding of these pathogens to SCARF1 and CD36 was     -glucan depen-
dent. Thus, CED-1/SCARF1 and C03F11.3/CD36 are     -glucan binding receptors and defi  ne 
an evolutionarily conserved pathway for the innate sensing of fungal pathogens. 
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Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/
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ulated in WT nematodes using RNAi (Fig. S1 a, available at 
http://www.jem.org/cgi/content/full/jem.20082109/DC1). 
Notably, both WT and CED-1 mutant nematodes have a 
normal lifespan in the presence of the nonpathogenic yeast 
  Cryptococcus laurentii   (unpublished data). 
  To determine if   CED-1   is also involved in the host response 
to other pathogens, we infected WT and CED-1 mutant worms 
with the common human pathogens   Salmonella typhimurium  , 
  Staphylococcus aureus  , and   Enterococcus faecalis  . By 144 h,     56% of 
CED-1 mutants died in response to   Salmonella   infection as 
compared with 25% of WT worms (Fig. S1 b), indicating that 
  CED-1   is also required, at least in part, for the innate immune 
response of   C. elegans   to this Gram-negative bacterium. In con-
trast, both WT and CED-1 mutant worms died at the same rate 
in response to   S. aureus   and   E. faecalis   infection (Fig. S1 c and 
not depicted), indicating that   CED-1   is not required for host 
defense to these organisms. 
  Gene expression profi  ling of WT   C. elegans   infected with 
  C. neoformans   revealed the up-regulation of several antimicrobial 
peptides, including antibacterial factor (abf) 1 and abf-2 (  Fig.1 c  ). 
These peptides have been shown to be up-regulated in response 
to bacterial pathogens and to have antifungal activity (  27, 28  ). 
To determine if induction of antimicrobial peptides is a down-
stream event from CED-1 binding to   C. neoformans  , we mea-
sured mRNA levels of   abf-1   and   abf-2   in WT and CED-1 
mutants 24 h after exposure to   C. neoformans  . Exposure of WT 
  C. elegans   to   C. neoformans   up-regulated mRNA levels of   abf-1   
and   abf-2   4.4- and 4.1-fold, respectively (  Fig. 1c   and not de-
picted). In contrast, CED-1 mutants exposed to   C. neoformans   
up-regulated   abf-1   and   abf-2   levels only 1.6- and 1.9-fold, re-
spectively (  Fig. 1c   and not depicted), indicating that CED-1 ex-
pression is required for maximal induction of these antimicrobial 
proteins. Of note, WT and CED-1 mutants up-regulated anti-
microbial peptide mRNAs equally in response to infection with 
  S. aureus   and   E. faecalis   (unpublished data). Collectively, these 
data suggest that   CED-1   is critical in protecting   C. elegans   from 
  C. neoformans   infection, and that expression of   CED-1   is re-
quired for induction of antimicrobial peptides that may play a 
role in the host response to fungal pathogens. 
    C03F11.3  , a   CD36   orthologue, mediates   C. elegans   survival 
after   C. neoformans   infection 
  Our search for potential   C. elegans   orthologues of the various 
mammalian scavenger receptors identifi  ed that only four of 
these receptors have possible   C. elegans   orthologues:   SCARF1   
(  CED-1  ),   CD36   (  C03F11.3     >     F11C1.3     >     R07B1.3     >   
  F07A5.3  ),   SCARB1   (  Y49E10.20  ), and   SCARB2   (  Y76A2B.6  ) 
(  25, 26  ). Because   CED-1   is involved in the host response to 
  C. neoformans   infection, and because scavenger receptors have 
been shown to play complementary roles to each other and 
share the same ligands (  18  ), we tested whether   C03F11.3  , 
  F11C1.3  ,   R07B1.3  ,   F07A5.3  ,   Y49E10.20  , or   Y76A2B.6   
are also involved in the nematode immune response to   C. 
neoformans   infection. 
  Silencing of the   C03F11.3   gene with siRNA led to increa-
sed susceptibly of the nematodes to   C. neoformans   infection and 
Alzheimer  ’  s disease, and in the host response to some bacte-
rial pathogens (  16  –  21  ). To date, a role for scavenger recep-
tors in the recognition of fungal and yeast pathogens has not 
been described. 
  Using an shRNA screen in mouse macrophages, we 
found that two evolutionarily conserved members of the 
scavenger receptor family, SCARF1 and CD36, and their 
  Caenorhabditis elegans   orthologues, CED-1 and C03F11.3, are 
required for the induction of protective immune responses in 
worms and mice to pathogenic yeast. We show that these re-
ceptors recognize     -glucans and have an essential function in 
antifungal immunity and host defense by mediating yeast 
binding and subsequent macrophage activation. 
    RESULTS   
  CED-1 mediates   C. neoformans   recognition in   C. elegans   
  To identify genes involved in the innate immune response to 
fungal pathogens, we used the nematode   C. elegans   as a model 
host for infection and   C. neoformans   as a prototypical fungal 
pathogen, as previously described (  22, 23  ). Because of the es-
tablished role of scavenger receptors in innate immunity to 
bacterial pathogens (  19  –  21  ), we explored whether this family 
of pattern recognition receptors also plays a role in innate 
immunity to fungal pathogens. Using a BLAST screen of the 
Wormbase database WS196, we searched for   C. elegans   or-
thologues of the mammalian scavenger receptors   SR-A1  , 
  SR-A2  ,   MARCO  ,   SCARF1  ,   CD36  ,   SCARB1  ,   SCARB2  , 
  CD68  ,   CXCL16  , and   Lox-1  . Interestingly, we found that 
only four of these receptors,   SCARF1  ,   CD36  ,   SCARB1  , and 
  SCARB2  , have possible   C. elegans   orthologues. As previously 
described, we found that   SCARF1   is a   CED-1   orthologue 
(  24  ). We also identifi  ed four potential   CD36   orthologues in 
the   C. elegans   genome (  C03F11.3     >     F11C1.3     >     R07B1.3     >   
  F07A5.3  ; ranked by amino acid alignment score to mouse 
  CD36  ), one potential   SCARB1   orthologue (  Y49E10.20  ), 
and one potential   SCARB2   orthologue (  Y76A2B.6  ; available 
from the Wormbase database at http://wormbase.org) (  25, 
26  ). We analyzed the role of each of these receptors in the 
pathogenesis of   C. neoformans   infection in   C. elegans  . 
  Gene expression profi  ling of WT   C. elegans   infected with 
  C. neoformans   revealed that the   SCARF1   orthologue   CED-1  , 
a scavenger receptor that mediates engulfment of cell corpses 
by   C. elegans   (  24  ), is up-regulated approximately fourfold 
compared with uninfected worms (  Fig. 1 a  ).   This fi  nding 
raised the interesting possibility that   CED-1   may be involved 
in the innate immune response to fungal pathogens. To ex-
plore this possibility, we obtained CED-1 mutants that do 
not express the receptor on the cell surface (strains MT4930 
and MT4933) (  24  ) and infected them with   C. neoformans  . We 
found that CED-1 mutants were signifi  cantly more suscepti-
ble to killing by   C. neoformans   than WT nematodes (MT4933 
strain shown;   Fig. 1 b  ). By 144 h after infection,     80% of the 
CED-1 mutants exposed to   C. neoformans   died compared 
with just     28% of WT nematodes (P   <   0.0001;   Fig. 1 b  ). 
Similar results were obtained with a second CED-1 mutant 
(strain MT4930) and when CED-1 expression was down-reg-JEM VOL. 206, March 16, 2009 
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As observed with   CED-1  ,   C03F11.3   expression in   C. elegans   
was also required for induction of the antimicrobial peptides abf-1 
and abf-2 (  Fig. 1 e   and not depicted), indicating that   C03F11.3  , 
rather than   F11C1.3  ,   R07B1.3  , or   F07A5.3  , is the   C. elegans   
  CD36   orthologue. Indeed, analysis of C03F11.3 showed that it 
has     53% similarity to mammalian CD36 and possesses two 
membrane-spanning domains similar to CD36 (Fig. S3, a and b). 
Silencing of   SCARB1   and   SCARB2   orthologues (  Y76A2B.6   
decreased survival (  Fig. 1, d and e  ). By 168 h after infection, 
    24% of control siRNA-treated   C. elegans   died in response to 
  C. neoformans   compared with     60% of worms treated with 
siRNA in response to   C03F11.3  . In contrast,   C. elegans   worms 
defi  cient in the expression of the other three potential   CD36   or-
thologues (  F11C1.3  ,   R07B1.3  , and   F07A5.3  ) survived   C. neo-
formans   infection, similar to WT worms (Fig. S2, a  –  c, available at 
http://www.jem.org/cgi/content/full/jem.20082109/DC1). 
    Figure 1.         CED-1 and C03F11.3 mediate recognition of   C. neoformans   in   C. elegans  .   (a) Increased   CED-1   expression in   C. elegans   infected  with 
  C. neoformans  . mRNA levels were measured by QPCR, as described in Materials and methods, after exposure of WT nematodes to   C. neoformans   for 
24 h. (b) Survival of WT N2 strain nematodes and CED-1 mutant strain MT4933 after exposure to   C. neoformans   strain H99. Survival was determined as 
described in Materials and methods, and p-values were determined using the Kaplan-Meier survival statistical test (  n     >   100 worms per strain). (c) mRNA 
levels for the antimicrobial peptide abf-1 were measured by QPCR 24 h after exposure of WT and CED-1 mutant strain MT4933 nematodes to   C. neofor-
mans  . (d) Survival of siRNA control L4440 strain and siC03F11.3 nematodes after exposure to   C. neoformans  . (e) mRNA levels for the antimicrobial pep-
tide abf-1 were measured by QPCR 24 h after exposure of L4440 and siC03F11.3 nematodes to   C. neoformans  . Data are representative of at least three 
independent experiments. Means   ±   SEM are shown.     640 SCAVENGER RECEPTORS AND INNATE IMMUNITY TO FUNGAL INFECTIONS   | Means et al. 
cDNA from a human endothelial cell cDNA library and estab-
lished a stable Chinese hamster ovary (CHO) cell line express-
ing SCARF1 (CHO-SCARF1;   Fig. 3 a  , top).   CHO-SCARF1 
cells, but not CHO control cells, gained the ability to bind 
nonopsonized   C. neoformans   (  Fig. 3 b  ). Antibodies to SCARF1 
blocked the binding of   C. neoformans   to CHO-SCARF1, indi-
cating that this binding is specifi  c (  Fig. 3 b  ). We also found that 
SCARF1 expression conferred a fi  vefold increase in cellular 
internalization of   C  .   neoformans   over mock-transfected control 
cells, indicating that SCARF1 acts as a phagocytic receptor for 
pathogenic yeast (  Fig. 3 c  ). In addition, human microvascular 
endothelial cells or monocyte-derived macrophages incubated 
with   C. neoformans   for 2 h in the presence of blocking anti-
SCARF1 antibodies showed an     55  –  60% reduction in bind-
ing (  Fig. 3 d   and not depicted), confi  rming that SCARF1 can 
mediate binding of mammalian cells to this pathogen. Staining 
of peritoneal macrophages with anti-SCARF1 antibodies con-
fi  rmed colocalization of the receptor with areas of   C. neofor-
mans   attachment (  Fig. 3 a  , bottom). 
  To further investigate the role of SCARF1 in the recogni-
tion of   C. neoformans  , we examined the ability of several soluble 
fungal-derived carbohydrates and classical scavenger receptor li-
gands to inhibit the binding of fl  uorescently labeled   C. neofor-
mans   to CHO-SCARF1 cells.     -Glucan, laminarin (a soluble 
fungal-derived     -glucan), acetylated low density lipoprotein 
(acLDL), poly I, fucoidan, and, to a lesser extent, mannan in-
hibited SCARF1 recognition of   C. neoformans   (  Fig. 3, e and f  ). 
In contrast, addition of dextran, pullulan, or poly C had no ef-
fect. These results suggested that binding of   C  .   neoformans   to 
SCARF1 is mediated in part by the recognition of     -1,3  –  linked 
and     -1,6  –  linked     -glucans. Although     -glucans in encapsu-
lated   C  .   neoformans   were thought to be hidden beneath the cap-
sule layer, recent evidence suggests that     -glucans are exposed 
on the cell surface and released during systemic fungal infections 
(  33, 34  ). To address this issue, we examined the ability of CHO 
cells expressing SCARF1 to directly bind zymosan (a classical 
    -glucan receptor ligand). We found a 3.5-fold increase in zy-
mosan binding to SCARF1 over mock-transfected CHO cells 
(  Fig. 4 a  ).   The binding of fl  uorescently labeled zymosan to 
SCARF1 was blocked by the addition of unlabeled     -glucan 
(  Fig. 4 a  ). Collectively, these data demonstrate that binding of 
  C. neoformans   by SCARF1 is mediated by the recognition of 
    -glucans (  35  ). Other receptors, most notably Dectin-1, have 
also been shown to bind     -glucans and other yeast and 
fungal organisms in a similar manner (  35  ). These data in-
dicate that SCARF1, in addition to Dectin-1, is a receptor 
for     -glucans. 
  In our RNAi screen, we found that silencing SCARF1 and 
TLR2 expression signifi  cantly reduced   C  .   neoformans    –  induced 
macrophage activation. Recently, SCARF1 was shown to co-
operate with TLR2 in mediating the recognition and cellular 
response to bacterial outer membrane protein A (  36  ). To deter-
mine if SCARF1 and TLR2 cooperate in the cellular response 
to  C  .  neoformans  , we stimulated CHO cells expressing SCARF1, 
TLR2, SCARF1/TLR2, SCARF1/TLR4, and SCARF1/
TLR9, and measured mRNA induction of the chemokine Gro 
and   Y49E10.20  ) had no eff  ect on the survival of   C. elegans   in re-
sponse to infection with   C. neoformans   (Fig. S2, d and e). This is 
the fi  rst description of C03F11.3 as a   C. elegans   membrane re-
ceptor. These data also demonstrate that the scavenger receptors 
CED-1 and C03F11.3 are novel members of an innate immune 
recognition pathway in   C. elegans   that have a direct role in the 
host defense against the yeast pathogen   C. neoformans.   
  shRNA screen identifi  es receptors that mediate 
  C. neoformans    –  induced mouse macrophage activation 
  To identify mammalian receptors involved in the host response 
to fungal pathogens, and to test if the mammalian orthologues 
of the nematode scavenger receptors CED-1 and C03F11.3 
are also involved in the host response to   C. neoformans   infec-
tion, we used a mouse shRNA library targeting innate immune 
receptors to screen for genes that mediate macrophage activa-
tion in response to this fungal pathogen. The RNAi Consor-
tium has previously stated that its lentiviral library silences genes 
in a diverse set of cell types, contains fi  ve shRNAs for nearly ev-
ery gene in the mouse genome, and is capable of signifi  cantly 
reducing target mRNA levels (Fig. S4, available at http://www
.jem.org/cgi/content/full/jem.20082109/DC1) (  29  ). Using a 
subset of the mouse lentiviral shRNA library targeting TLRs, 
scavenger receptors including   CED-1   orthologues, c-type lec-
tins, and other pattern recognition receptors (  Fig. 2 a  ), we per-
formed a screen to identify genes that mediate macrophage 
activation induced by   C. neoformans   stimulation using RAW 
264.7 (RAW) macrophages.     C. neoformans   induced a broad 
spectrum of cytokines and chemokines in RAW cells, includ-
ing IL-1     and MIP-2 (unpublished data). Silencing of the 
scavenger receptors   CD36  ,   SCARF1  , or   SCARB2   led to a 
signifi   cant reduction in   C. neoformans    –  induced IL-1     and 
MIP-2 mRNA in macrophages (  Fig. 2 b   and not depicted). In 
addition, our shRNA screen confi  rmed the role of genes already 
known to be involved in the innate response to fungal patho-
gens, such as   TLR2  . Importantly, this mammalian shRNA 
screen confi  rmed our   C. elegans   data by demonstrating that or-
thologues of   CED-1   (  SCARF1  ) and   C03F11.3   (  CD36  ) medi-
ate macrophage responsiveness to   C. neoformans  . Gene silencing 
of   MEGF10   and   LRP1  , two other potential orthologues of 
  CED-1   also expressed by macrophages, had no eff  ect on   C. neo-
formans    –  induced macrophage activation (  Fig. 2 b  ), indicating 
that   SCARF1   is the mammalian   CED-1   orthologue responsible 
for recognition of   C. neoformans  . Interestingly, our screen also 
implicated   SCARB2  , a lysosomal protein, in the cytokine re-
sponse to   C. neoformans  , suggesting a novel role for lysosomal 
proteins in regulating cytokine responses to fungal infection. 
  SCARF1 mediates recognition of   C. neoformans   
and   C. albicans   
  SCARF1 is expressed on macrophages and endothelial cells 
(  30  ), and both cell types play an important role in host interac-
tions with   C. neoformans  . Macrophages phagocytose and kill 
  C. neoformans   (  31  ), and binding of these fungi to endothelial cells 
initiates tissue invasion (  32  ). To test the ability of SCARF1 to 
bind and phagocytose   C. neoformans  , we isolated the   SCARF1   JEM VOL. 206, March 16, 2009 
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mice were killed and alveolar macrophages were harvested 
by alveolar lavage. We chose a pulmonary challenge for the 
in vivo antibody experiment instead of the systemic one, be-
cause the duration of the lethality experiment in vivo (up to 
12  –  14 d) would require frequent injections of large amounts 
of anti-SCARF1 antibodies injected i.v., complicated by 
spleen- or liver-mediated fi  rst-pass clearance of the antibodies. 
In contrast, the lung off  ers a relatively contained space that 
in these cells (  Fig. 4 b  ). We found that TLR2 but not TLR4 or 
TLR9 expression conferred responsiveness to   C  .   neoformans   and 
that coexpression of SCARF1 and TLR2 synergized for maxi-
mal responsiveness to   C. neoformans   stimulation (  Fig. 4 b  ). 
  To determine if SCARF1 mediates recognition of   C. neo-
formans   in vivo, we instilled fl  uorescently labeled   C. neofor-
mans   in the lungs of WT mice in the presence or absence of 
neutralizing anti-SCARF1 or control antibodies. 2 h later, the 
    Figure 2.         Expression and shRNA knockdown of pattern recognition receptors on RAW mouse macrophages stimulated with   C. neoformans  .  
(a) RAW macrophages were transduced with lentivirus encoding gene-specifi  c shRNAs to 30 pattern recognition receptors or with a control shRNA di-
rected against GFP. Gene expression was measured by QPCR, and three to fi  ve individual shRNAs per gene were identifi  ed that signifi  cantly reduced 
mRNA expression. (b) Pattern recognition receptor expression was knocked down in individual pools of RAW macrophages, which were then stimulated 
with   C. neoformans  . After 4 h, total RNA was isolated from the cells, and the expression of IL-1     was measured by QPCR. Data are expressed as means   ±   
SEM of three independent experiments. *, P   <   0.007 versus control using the Student  ’  s   t   test.   642 SCAVENGER RECEPTORS AND INNATE IMMUNITY TO FUNGAL INFECTIONS   | Means et al. 
    Figure 3.         SCARF1 mediates binding to   C. neoformans  .   (a, top) CHO cells transfected with the CED-1 orthologue SCARF1 (CHO-SCARF1), but not vector 
transfected cells (CHO-PURO), stain with fl  uorescently labeled anti-SCARF1 antibodies (green). CHO-SCARF1 cells do not stain with control antibodies. (bottom) 
Peritoneal macrophages were incubated with FITC-labeled   C. neoformans   (green) and stained with anti-SCARF1 antibodies (red). Nuclei were stained with DAPI 
(blue). Bars: (top) 10   μ  m; (bottom) 1   μ  m. (b) CHO-SCARF1 cells bind unopsonized fl  uorescently labeled   C. neoformans  , as measured by fl  ow cytometry. Anti-
SCARF1 antibodies block binding of unopsonized   C. neoformans   to CHO-SCARF1. *, P   <   0.01 versus CHO-SCARF1. (c) Flow cytometry measurement of cell inter-
nalization of   C .   neoformans   using the Trypan blue quenching assay described in Materials and methods.   C. neoformans   internalization is increased fi  vefold in 
SCARF1-transfected CHO cells relative to mock transfected cells. (d) Anti-SCARF1 but not isotype control antibodies block binding of unopsonized   C. neofor-
mans   to human monocyte-derived macrophages, as measured by fl  ow cytometry. (e and f) CHO-SCARF1 cells were pretreated with 10, 100, or 500   μ  g/ml of 
carbohydrates or other classical scavenger receptor ligands before the addition of fl  uorescently labeled   C. neoformans   (20 per cell).   C. neoformans   binding was 
quantifi  ed on a fl  uorescent microplate reader and is expressed relative to an uninhibited control. Background binding of   C. neoformans   to control CHO cells 
was normally     15  –  20%. Dotted lines indicate the 100% level. Data are representative of at least three independent experiments. Means   ±   SEM are shown.    
allows performance of the experiment within hours, before 
diff  usion and/or clearance of the antibodies. We found that 
  C. neoformans   binding in vivo to alveolar macrophages was in-
hibited     32% by the presence of anti-SCARF1 antibodies 
(  Fig. 4 c  ). These data indicate that SCARF1 is involved in the 
recognition of fungal pathogens in vivo. JEM VOL. 206, March 16, 2009 
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microbial products (i.e., bacterial diacylated lipoproteins and 
lipoteichoic acid) that signal via TLR2. As shown in   Fig. 2 b  , 
down-regulation of   CD36   or   TLR2   expression by shRNA in 
RAW macrophages signifi  cantly reduced cytokine induction 
in response to   C. neoformans  . These results suggest that, like its 
  C. elegans   orthologue C03F11.3, CD36 is also involved in the 
interaction of mammalian macrophages with fungal patho-
gens. To test whether mammalian CD36 also mediates bind-
ing to yeast pathogens, we used CHO cells expressing CD36 
(CHO-CD36) and found that these cells gained the ability to 
bind   C. neoformans   in contrast to control CHO cells (  Fig. 5 a  ).   
Because TLR2 expression on macrophages has previously 
been shown to be required for   C. neoformans    –  induced cyto-
kine production (  9, 11, 37  ), we generated CHO cells stably 
expressing human CD36, TLR2, or CD36/TLR2. These 
  Because fungal pathogens share several cell-wall molecules, 
we tested whether SCARF1 could mediate binding to other 
fungal pathogens. We found that CHO-SCARF1 cells bind 
  C. albicans   in a     -glucan  –  dependent manner (  Fig. 4 d  ). As ex-
pected, control CHO cells bound a negligible number of or-
ganisms. Therefore, CED1/SCARF1 are involved in binding 
and the innate response to   C. neoformans   and   C. albicans.   These 
data demonstrate that these receptors are components of a pre-
viously uncharacterized, evolutionarily conserved pathway for 
fungal pathogen recognition and innate immunity. 
  CD36 but not TLR2 expression is required for   C. neoformans   
cell binding 
  CD36 is a class B scavenger receptor that is a sensor for en-
dogenous molecules (i.e.,     -amyloid and modifi  ed LDL) and 
    Figure 4.         SCARF1 mediates binding of     -glucan and   C  .   neoformans   in vitro and in vivo, and cooperates with TLR2 to mediate cell activation.  
(a) 50   μ  g/ml of FITC-labeled zymosan was added to CHO and CHO-SCARF1 cells in the presence or absence of 100   μ  g/ml of unlabeled    -glucan.  Zymosan 
binding was quantifi  ed on a fl  uorescent microplate reader. (b) Total RNA was isolated from 10  6   SCARF1, TLR2, SCARF1/TLR2, SCARF1/TLR4/MD2, SCARF1/
TLR9, or control CHO cells stimulated with   C. neoformans   at a ratio of 20:1 for 4 h. Expression of Gro was determined by QPCR and is depicted as the num-
ber of copies of Gro mRNA per copies of the control   GAPDH   mRNA. (c) Fluorescently labeled   C. neoformans   was instilled in the lungs of WT mice (  n   = 8) in 
the presence of anti-SCARF1 or isotype control antibodies. 2 h later, alveolar macrophages were harvested and analyzed for   C. neoformans   binding by fl  ow 
cytometry. (d) Binding of fl  uorescently labeled   C. albicans   to CHO and CHO-SCARF1 cells was measured by fl  ow cytometry in the presence or absence of 
100   μ g/ml     -glucan. Data are representative of at least three independent experiments. Means   ±   SEM are shown. *, P   <   0.01 versus CHO-SCARF1.   644 SCAVENGER RECEPTORS AND INNATE IMMUNITY TO FUNGAL INFECTIONS   | Means et al. 
phages showed a 50  –  60% impairment in the cellular inter-
nalization of   C  .   neoformans   relative to WT macrophages, 
indicating that CD36 mediates internalization of pathogenic 
yeast (  Fig. 6 c  ). We also found that a CD36-Fc fusion protein, 
but not a control fusion protein encoding RAGE-Fc, inhib-
ited macrophage binding to   C. neoformans   (  Fig. 6 d  ). Further-
more, neutralizing antibodies to TLR2 had no eff  ect on 
macrophage binding to   C. neoformans  . These data indicate that 
CD36, but not TLR2 or RAGE, is required for optimal bind-
ing of   C neoformans   to macrophages. 
  To determine if CD36 expression on macrophages medi-
ates   C. neoformans    –  induced cytokine production, we stim-
ulated macrophages isolated from WT and   CD36      /        mice 
and measured IL-1     expression by quantitative real-time 
PCR (QPCR). As a control, we isolated macrophages from 
  RAGE      /       ,   SR-A      /       , and   LOX-1      /        mice. We found that 
CD36 expression on macrophages was required for   C. neofor-
mans    –  induced IL-1     expression, whereas macrophages from 
  RAGE      /       ,   SR-A      /       , and   LOX-1      /        mice responded simi-
larly to WT macrophages (  Fig. 6 e  ). Moreover, we found 
that   C. neoformans   induced the expression of IL-1    , TNF, 
IL-12  p40  , IFN-    , MIP-2, MIP-1    , MIP-1    , RANTES, and 
IP-10 from WT macrophages (  Fig. 6 f  ). In contrast,   CD36      /        
macrophages stimulated with   C. neoformans   had a signifi  cant 
reduction in the expression of IL-1    , TNF, IL-12  p40  , MIP-2, 
MIP-1    , MIP-1    , and RANTES, whereas the induction of 
IFN-     and IP-10 was similar to WT macrophages (  Fig. 6 f  ). 
TLR2 ligation is not required for induction of the IFN path-
way or production of IFN-induced chemokines such as IP-10. 
In this context, because CD36 appears to be collaborating 
with TLR2 in mediating   C. neoformans   responses, our results 
are not surprising and support the published literature (  41, 
42  ). To determine whether the increases in mRNA levels 
were accompanied by protein production, we stained WT 
and   CD36      /        macrophages stimulated with   C. neoformans   
with fl  uorescently labeled anti-TNF and anti  –  MIP-1     anti-
bodies, and measured protein expression of these two cyto-
kines by intracellular fl   ow cytometry. The results were 
consistent with the mRNA data.   C. neoformans   stimulation 
induced MIP-1     and TNF protein production in WT mac-
rophages but not in   CD36      /        macrophages (  Fig. 6 g  ). In 
contrast, bacterial LPS induced the production of MIP-1     
and TNF equally in WT and   CD36      /        macrophages (un-
published data). These data show that CD36, but not SR-A, 
RAGE, or LOX-1, is a major macrophage receptor mediat-
ing macrophage activation by   C. neoformans  . 
  To determine the relative contribution of CD36 and 
TLR2 expressed on primary WT macrophages in the re-
sponse to   C. neoformans  , we stimulated these cells in the pres-
ence or absence of recombinant CD36-Fc and/or neutralizing 
anti-TLR2 antibodies. As a control, WT macrophages were 
stimulated with   C. neoformans   in the presence of RAGE-Fc 
or isotype control antibody. CD36-Fc and anti-TLR2 indi-
vidually blocked     45  –  55% of   C. neoformans    –  induced IL-1     
expression. Combining both inhibitors blocked   >  75% of IL-
1     induction (  Fig. 6 h  ). In contrast, control antibody and 
cells were then tested for their ability to bind unopsonized   C. 
neoformans.   We found that CD36 but not TLR2 expression 
was required for optimal binding of   C. neoformans   (  Fig. 5 b  ). 
In addition, we found that a CD36-Fc fusion protein, but not 
a control RAGE-Fc fusion protein or neutralizing antibodies 
to TLR2, inhibited   C. neoformans   cell binding to CHO/
CD36/TLR2-expressing cells (  Fig. 5 c  ). These results dem-
onstrate that CD36 but not TLR2 expression is required for 
binding   C. neoformans  . 
  Recently, CD36 was also shown to act as a coreceptor for 
TLR2 in mediating responses to diacylated lipoproteins and 
lipoteichoic acid isolated from   S. aureus   (  38  –  40  ). In addition, 
TLR2 has been shown to collaborate with Dectin-1 to medi-
ate responsiveness to     -glucans and live fungal pathogens 
(  9, 11  ). To determine the relative contribution of CD36 and 
TLRs to   C. neoformans    –  induced cell activation, we stimulated 
CHO cells expressing CD36, TLR2, CD36/TLR2, CD36/
TLR4, or CD36/TLR9 with   C. neoformans   and measured in-
duction of the mRNA for the chemokine Gro in these cells 
(  Fig. 5 d  ). Expression of TLR2 alone but not of CD36 led 
to a modest up-regulation of Gro in transfected CHO cells 
stimulated with   C. neoformans  . Interestingly, coexpression of 
CD36 and TLR2 dramatically increased Gro mRNA expres-
sion in response to   C. neoformans   (  Fig. 5 d  ). In contrast, coex-
pression of CD36 with TLR4 or TLR9 did not aff  ect   C. 
neoformans   activation of these cells. These data indicate that 
CD36 and TLR2 but not TLR4 or TLR9 collaborate in me-
diating the innate immune response to yeast infection. 
  To further characterize the role of CD36 in the recogni-
tion of   C. neoformans  , we examined the ability of several fun-
gal-derived carbohydrates, and the well-established scavenger 
receptor ligands modifi  ed LDL and fucoidan, to inhibit the 
binding of fl  uorescently labeled   C. neoformans   to CHO-CD36 
cells.     -Glucan, laminarin, fucoidan, and modifi  ed LDL in-
hibited CD36 binding to   C. neoformans   (  Fig. 5 e  ). In contrast, 
the addition of mannan, dextran, or pullulan had minimal or 
no eff  ect. These results suggest that binding of   C. neoformans   to 
CD36 is mediated in part by the recognition of     -glucans. To 
determine if CD36 directly binds     -glucan, we examined the 
ability of CHO cells expressing CD36 to bind zymosan. We 
found a 4.2-fold increase in zymosan binding to CD36 over 
mock-transfected CHO cells (  Fig. 5 f  ). The binding of fl  uores-
cently labeled zymosan to CD36-expressing CHO cells was 
inhibited by addition of unlabeled     -glucan (  Fig. 5 f  ). Collec-
tively, these results demonstrate that binding of   C. neoformans   
by CD36 is mediated in part by the recognition of     -glucans. 
  CD36 expression on macrophages is required 
for   C. neoformans   and   C. albicans   binding 
and cytokine production 
  To determine whether CD36 expression mediates binding to 
  C. neoformans   on primary cells, we isolated macrophages from 
WT and CD36      /      mice and stimulated them with   C. neofor-
mans   in vitro  .   We found that CD36-defi  cient macrophages 
had a marked reduction in binding to   C. neoformans   (  Fig. 6, 
a and b  ).   In addition, we found that CD36-defi  cient macro-JEM VOL. 206, March 16, 2009 
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    Figure 5.         CD36 is required for   C. neoformans   cell adhesion, and TLR2 cooperates with CD36 to mediate   C. neoformans    –  induced cell 
activation.   (a and b) Fluorescently labeled   C. neoformans   were incubated with CHO-CD36, CHO-TLR2, CHO-CD36/TLR2, or control CHO-NEO cells for 
1 h, washed, and subjected to fl  ow cytometry. *, P   <   0.01 versus CHO; **, P   <   0.01 versus CHO-CD36. (c) Fluorescently labeled   C. neoformans   were 
incubated with CHO-CD36/TLR2 cells in the presence or absence of 25   μ  g/ml CD36-Fc, 25   μ  g/ml RAGE-Fc, 50   μ  g/ml anti-TLR2, or 50   μ  g/ml of control 
IgG, as indicated.   C. neoformans   binding was quantifi  ed on a fl  uorescent microplate and is expressed relative to an uninhibited control. *, P   <   0.001. 
(d) Total RNA was isolated from 10  6   CD36, TLR2, CD36/TLR2, CD36/TLR4, CD36/TLR9 or control CHO cells stimulated with   C. neoformans   at a ratio of 
20:1 for 4 h. Expression of Gro was determined by QPCR and is depicted as the number of copies of Gro mRNA per copies of the control GAPDH 
mRNA. Data are representative of four similar experiments. (e) CHO-CD36 cells were pretreated with 10, 100, or 500   μ  g/ml of carbohydrates, fucoi-
dan, or acLDL before addition of fl  uorescently labeled   C. neoformans   (20 per cell).   C. neoformans   binding was quantifi  ed on a fl  uorescent microplate 
reader and is expressed relative to an uninhibited control. Background binding of   C. neoformans   to control CHO cells was normally    15 – 20%.  The 
dotted line indicates the 100% level. (f) 50   μ  g/ml of FITC-labeled zymosan was added to CHO and CHO-CD36 cells in the presence or absence of 
100   μ  g/ml of unlabeled     -glucan. Zymosan binding was quantifi  ed on a fl  uorescent microplate reader. Data in e and f are representative of four 
independent experiments with similar results. Means   ±   SEM are shown.     646 SCAVENGER RECEPTORS AND INNATE IMMUNITY TO FUNGAL INFECTIONS   | Means et al. 
    Figure 6.         CD36 expression mediates macrophage recognition of   C. neoformans  .   (a and b) Fluorescently labeled   C. neoformans   were  incubated 
with macrophages isolated from WT and   CD36    /      mice for 1 h and washed; cell association was measured by fl  ow cytometry. *, P   <   0.01 versus WT. 
(c) Flow cytometry measurement of cell internalization of   C .   neoformans   using the Trypan blue quenching assay described in Materials and methods. 
  C .   neoformans   internalization was increased threefold in CD36-transfected CHO cells relative to mock transfected cells. *, P   <   0.001. (d) Fluorescently labeled 
  C. neoformans   were incubated with WT mouse macrophages in the presence or absence of 25   μ  g/ml CD36-Fc, 25   μ  g/ml RAGE-Fc, 50   μ  g/ml anti-TLR2, or 
50   μ  g/ml of control IgG, as indicated.   C. neoformans   binding was quantifi  ed on a fl  uorescent microplate and is expressed relative to an uninhibited control. 
*, P   <   0.001. (e and f) Total RNA was extracted from 10  6   macrophages isolated from WT,   CD36    /    ,   RAGE    /    ,   SR-A    /     , and   LOX-1    /      mice stimulated with JEM VOL. 206, March 16, 2009 
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  C. neoformans   at a ratio of 20:1 for 4 h. Expression of cytokines and chemokines was determined by QPCR and is depicted as the number of copies of 
mRNA per copies of the control GAPDH mRNA (e) or fold treated over untreated (f). *, P   <   0.001. (g) WT and CD36     /     macrophages were stimulated with 
  C. neoformans   (20:1) for 6 h. Protein expression of the cytokine TNF and the chemokine MIP-1     was determined by intracellular fl  ow cytometry. (h) Total 
RNA was isolated from WT macrophages (10  6   cells) stimulated with   C. neoformans   at a ratio of 20:1 for 4 h in the presence or absence of CD36-Fc, RAGE-
Fc, anti-TLR2, or control IgG. Expression of   IL-1     was determined by QPCR and is depicted as the number of copies of IL-1     mRNA per copies of the con-
trol mRNA   GAPDH  . Data are representative of four similar experiments. Means   ±   SEM are shown. *, P   <   0.001.     
 
RAGE-Fc had no eff  ect on   C. neoformans    –  induced IL-1     ex-
pression. These data confi  rm our shRNA data and demon-
strate that expression of both CD36 and TLR2 are necessary 
for maximal responsiveness to   C. neoformans  . 
  To test whether CD36 could recognize other fungal 
pathogens, we stimulated WT and   CD36      /        macrophages 
with   C. albicans   and measured cytokine and chemokine in-
duction by QPCR. We found that   C. albicans   induced the 
expression of IL-1    , TNF, IL-12  p40  , IFN-    , MIP-2, MIP-
1    , MIP-1    , RANTES, and IP-10 from WT macrophages 
(Fig. S5 a, available at http://www.jem.org/cgi/content/
full/jem.20082109/DC1). In contrast,   CD36      /        macro-
phages stimulated with   C. albicans   had a marked reduction in 
the expression of IL-1    , TNF, IL-12  p40  , MIP-2, MIP-1    , 
MIP-1    , and RANTES, whereas the induction of IFN-     
and IP-10 was similar to WT macrophages (Fig. S5 a). We 
also found that CHO-CD36 cells bind   C. albicans   in a     -glu-
can  –  dependent manner (Fig. S5 b). Finally, we found that 
CD36-defi  cient macrophages showed an     50% reduction in 
binding   C. albicans   relative to WT macrophages (Fig. S5 c). 
Collectively, these data demonstrate that   C. elegans   C03F11.1 
and its mammalian orthologue CD36 are components of a 
previously uncharacterized, evolutionarily conserved path-
way for fungal pathogen recognition. 
  Effects of CD36 defi  ciency after in vivo infection 
with   C. neoformans   
  To study the role of CD36 in fungal infections in vivo, WT 
and   CD36      /        mice were infected i.v. with the virulent   C. 
neoformans   strain H99. The i.v. route of infection was used 
because it mimics the hematogenous spread observed when 
the organism disseminates, and because it is more reproduc-
ible and easier to accurately inoculate the same amount into 
each mouse. To assess the course of   C. neoformans   infection, 
the spleen and liver were harvested from WT and   CD36      /        
mice on day 5 after i.v. infection.   CD36      /        mice displayed 
signifi  cantly increased numbers of CFUs in the spleen and 
liver at day 5 compared with WT mice (  Fig. 7, a and b  ).   To 
visualize the number of yeast in the liver samples, we stained 
liver sections with calcofl  uor. We found signifi  cantly more 
  C. neoformans   in liver sections from   CD36      /        mice compared 
with WT mice (  Fig. 7, c and d  ), confi  rming results obtained 
from our microbiological assay. 
  To further confi  rm the yeast CFU counts, we designed 
primers to the cryptococcus capsule A gene and determined 
the number of copies in each organ by QPCR. The crypto-
coccal capsule plays an important role in the pathogenesis of 
cryptococcal infection, and expression of this mRNA refl  ects 
the presence and viability of the organism (  43  ). As expected, 
mRNA expression of the capsule A gene paralleled the number 
of CFU counts (  Fig. 7, e and f  ). 
  To test whether the fungal load diff  erences seen in WT and 
  CD36      /        mice correlated with the induction of proinfl  amma-
tory mediators, we determined the level of cytokines and che-
mokines induced in the spleen and liver 5 d after i.v. infection 
with   C. neoformans  . We found that several chemokines (MIP-2, 
MCP-1, MIP-1    , and MIP-1    ) and cytokines (IL-1    , TNF, 
and IL-12  p40  ) were induced in the organs of   C. neoformans    –  in-
fected WT mice (  Fig. 7, g and h  ). In contrast, all of these cyto-
kines were markedly reduced in the organs of   CD36      /        mice 
(  Fig. 7, g and h  ). To analyze whether loss of CD36 expression 
aff  ects the susceptibility of mice to   C  .   neoformans  , we infected 
WT and   CD36      /        mice i.v. with   C  .   neoformans  . We found that 
  CD36      /        mice succumbed to   C. neoformans   (2.5   ×   10  5   CFU) 
infection signifi  cantly faster than WT mice (  Fig. 7 i  ). When 
lower doses (10  5   CFU) of   C. neoformans   were used, similar re-
sults were obtained. However, at lower doses of   C. neoformans  , 
100% mortality in the   CD36      /        mice was delayed by 5 d com-
pared with the higher doses. In all experiments, we found that 
  CD36      /        mice succumbed at a signifi  cantly faster rate than 
WT mice regardless of the dose. Of note, expression of the 
other known     -glucan receptors Dectin-1, Dectin-2, mannose 
receptor, and TLR2 were not aff  ected in   CD36      /        macro-
phages (Fig. S6, available at http://www.jem.org/cgi/content/
full/jem.20082109/DC1). Collectively, these data show that 
CD36 expression is required for   C. neoformans    –  induced cyto-
kine and chemokine production in vivo, and demonstrate that 
CD36 is a cellular receptor for strains of   C. neoformans   that are 
pathogenic to humans and mice, and plays a crucial role in the 
host response to this organism. 
    DISCUSSION   
  Opportunistic yeasts cause signifi  cant morbidity and mortality 
in patients with impaired immune systems. Several yeast cell-
wall proteins are recognized by the innate immune system in 
mice and humans; however, the molecular mechanisms and 
receptors used by immune cells to bind and trigger cell activa-
tion have not been fully elucidated. In this paper, we show 
that the   C. elegans   receptors CED-1 and C03F11.3, and their 
mammalian orthologues, the scavenger receptors SCARF1 
and CD36, mediate host defense against pathogenic yeast. In 
the absence of CED-1 or C03F11.1, nematodes succumb 
much faster to fungal infection and fail to induce the produc-
tion of antimicrobial peptides. In mammalian cells, SCARF1 
and CD36 mediate binding and the subsequent induction 
of infl  ammatory cytokines and chemokines after exposure to 648 SCAVENGER RECEPTORS AND INNATE IMMUNITY TO FUNGAL INFECTIONS   | Means et al. 
    Figure 7.         Fungal burden, cytokine expression, and mortality of WT and CD36      /      mice after infection with   C. neoformans  .   (a and b) WT and 
CD36     /     mice were infected i.v. with 10  5    C. neoformans   organisms. Mice were killed 5 d after infection, and the numbers of CFUs in the spleen and liver 
were determined. Data are expressed as CFU per milligram of tissue. The fi  gure represents the combined results of two independent experiments, and the 
results are expressed as means   ±   SEM of eight mice per group. p-values are as indicated (Student  ’  s   t   test). (c and d) WT and   CD36    /      mice were infected 
i.v. with 10  5    C. neoformans   organisms. Mice were killed 5 d after infection, and 7-  μ  m liver sections were fi  xed in 100% methanol for 5 min and stained 
with a Fungi-Fluor kit. Photos were taken using a Nikon DXM 1200C camera and Nis-Elements AR software. Bars, 5   μ  m. (e and f) Total RNA was extracted 
from a portion of the spleen and liver isolated from WT and   CD36    /      mice infected i.v. with 10  5    C. neoformans   organisms 5 d after infection. The expres-
sion of the cryptococcus capsule A gene was determined by QPCR. p-values are as indicated (Student  ’  s   t   test). (g and h) QPCR was used to measure the JEM VOL. 206, March 16, 2009 
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expression of cytokines and chemokines in the spleen and liver of   C. neoformans    –  infected mice. Data are representative of three similar experiments us-
ing eight mice per group. *, P   <   0.01. (i) Survival of WT and   CD36    /      mice after i.v. infection of 2.5   ×   10  5    C .   neoformans  . Survival was determined as de-
scribed in Materials and methods, and p-values were determined using the Kaplan-Meier survival statistical test (P   <   0.003). Data are representative of 
three similar experiments using eight mice per group.     
 
  C. neoformans   and   C. albicans  . Furthermore, binding of C.   neo-
formans   and   C. albicans   to SCARF1 and CD36 is     -glucan 
dependent. The role of CD36 in these responses appears to be 
nonredundant in vivo, because the number of yeast cells in 
the spleen and liver of   C. neoformans    –  infected   CD36      /        mice 
were signifi  cantly higher than WT mice, and   CD36      /        mice 
died at an accelerated rate after   C. neoformans   infection, indi-
cating an essential role of CD36 in controlling the infection. 
Furthermore, the expression of proinfl  ammatory cytokines in 
the organs of   C. neoformans    –  infected   CD36      /        mice were 
signifi  cantly reduced compared with WT mice. Collectively, 
these data demonstrate that the scavenger receptors SCARF1 
and CD36 are nonredundant components of an evolution-
arily conserved pathway for fungal recognition and innate 
immunity that is necessary for controlling fungal infections in 
vivo. SCARF1 and CD36 do not appear to signal on their 
own in response to fungal binding; instead, they collaborate 
with TLR2 but not TLR4 or TLR9 for induction of cyto-
kines. It is possible that collaboration of diff  erent scavenger 
receptors with diff  erent TLRs is determined by the ligand at 
hand. Diff  erent ligands may trigger diff  erent collaborations 
between these two classes of pattern recognition receptors. 
  An important aspect of our fi  ndings is refl  ected by the role 
of   CED-1   and   C03F11.3   genes in   C. elegans.   We have previ-
ously established   C. elegans   as a simple model host in which 
yeast pathogenesis can be studied. CED-1 is a phagocytic re-
ceptor known to mediate the engulfment of dying cells. Our 
studies identify a novel role for CED-1 in host defense. Nema-
todes defi  cient in CED-1 are more rapidly killed by the yeast 
pathogen   C. neoformans   and the Gram-negative bacteria   S. ty-
phimurium   than WT worms, and fail to produce the antimicro-
bial peptides abf-1 and abf-2 in response to these infections. To 
our knowledge, this is the fi  rst demonstration of a role for 
CED-1 in fungal recognition and host defense. Recently, 
Haskins et al. demonstrated that CED-1 was required for the 
survival of   C. elegans   after infection with the human pathogen 
  S. enteric   strain 1344 (  44  ). Collectively, these data demonstrate 
that CED-1 is critical in the   C. elegans   immune response to live 
yeast and Gram-negative bacteria, and confi  rm the role of this 
receptor as an innate immune receptor. CED-1 does not appear 
to act alone as an innate immune receptor, as C03F11.3 also 
plays a nonredundant role in the nematode response to fungal 
infection. We are currently investigating if these two receptors 
play complementary roles in host defense against fungal as well 
as bacterial pathogens. Our data show that there is a remarkable 
similarity between the role of   C. elegans   and mammalian scav-
enger receptors in innate immunity. Indeed, just as   C. elegans   
scavenger receptors are necessary for antimicrobial peptide pro-
duction, mammalian scavenger receptors are required for cyto-
kine production in response to fungal pathogens. 
  Identifying the receptors responsible for pathogen recog-
nition is essential to understanding the innate immune system. 
Several classes of pathogen recognition receptors have now 
been described, each capable of recognizing and responding to 
conserved microbial structures. Scavenger receptors are cell-
surface proteins present on a variety of cell types. Although 
scavenger receptors have been primarily studied for their abil-
ity to bind endogenous modifi  ed LDL and     -amyloid, they 
also recognize and respond to pathogens (  19, 20  ). Scavenger 
receptors recognize a myriad of microbial structures, including 
LPS, lipoteichoic acid, DNA, and RNA. A role for scavenger 
receptors in the recognition of fungal pathogens has not been 
established. Recently, Rice et al. found indirect evidence for 
the involvement of scavenger receptors in the innate sensing 
of fungal pathogens. They showed that acLDL, a common li-
gand for many scavenger receptors, inhibits     -glucan binding 
to monocytes (  45  ). Our data show that SCARF1 and CD36, 
both of which bind acLDL, serve a nonredundant role as re-
ceptors for     -glucans. Interestingly, although the role of other 
    -glucan receptors in fungal pathogens in vivo remains un-
clear (  13, 15  ), our data indicate that SCARF1 and CD36 play 
important roles in vivo in controlling fungal infection. 
  In our shRNA screen, we also found that TLR2 was re-
quired for maximal cytokine and chemokine production from 
macrophages stimulated with live   C. neoformans  . Several TLRs 
(TLR2, TLR4, TLR6, and TLR9) have been shown to be 
involved in triggering macrophage activation by   C. neoformans  , 
  C. albicans  , or fungal-derived molecules (  46  –  49  ). In vitro ex-
periments have shown that CD14 cooperates with TLR2 and 
TLR4 in binding to the major component of the   C. neofor-
mans   capsule, polysaccharide glucuronoxylomannan. How-
ever, CD14, TLR2, and TLR4 appear to only play relatively 
minor roles in vivo in the host response to   C. neoformans   (  37, 
49  ). TLR2  –  6 heterodimers are involved in recognition of 
zymosan; however, cytokine production in TLR6-defi  cient 
macrophages is only moderately reduced in response to zymo-
san (  50  ). Similar to TLR6, the absence of TLR9 on macro-
phages results in only a moderate reduction in cytokine 
production after stimulation with fungal pathogens (  51  ). These 
data are consistent with our fi  ndings that silencing the expres-
sion of TLR2, but not TLR4, TLR6, or TLR9, in macro-
phages resulted in reduced cytokine production in response to 
live   C. neoformans   stimulation. 
  Other receptors, including Dectin-1, mannose receptor, 
Galectin-3, and Mincle, have been shown to bind yeast or to 
components of its capsule or cell wall (i.e.,     -glucan and man-
nans) (  8, 9, 52, 53  ). Dectin-1 cooperates with TLR2 for the 
production of infl  ammatory cytokines in response to     -glucan 
stimulation (  11, 12  ). However, Nakamura et al. did not fi  nd any 
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ture dishes and infected using 5   μ  l of shRNA lentiviral supernatant and 7.5 
  μ  g/ml polybrene. The cells were spun for 30 min at 2,000 rpm and incu-
bated for 24 h. To select for shRNA integration, the infected cells were 
placed in 3   μ  g/ml puromycin and RPMI 1640 containing 10% FBS. The cells 
were tested 1  –  2 wk after infection. 
  Infection and survival assays in   C. elegans  .       C. elegans   strain N2 Bristol 
was maintained at 15  °  C. All   C. elegans   strains were propagated on   Escherichia 
coli   strain OP50 using established procedures, as previously described (  22, 23, 
57  –  59  ).   C. elegans   survival assays in the presence of   C. neoformans  ,   S. ty-
phimurium  ,   S. aureus  , and   E. faecalis   were performed as previously described 
(  22, 23, 57, 58  ). We performed the   C. elegans   survival assays using males as 
well as hermaphrodite nematodes, because we have previously observed that 
some pathogens such as   C. neoformans   and   E. faecalis   can induce the internal 
hatching of eggs in some hermaphroditic worms, leading to matricide (  22, 
23, 57, 58  ). Because no diff  erences were seen between the responses of male 
worms or hermaphrodites, the diff  erences observed in survival between WT 
and mutants are caused by infection and not by this potential matricidal ef-
fect. For these studies, we used the well characterized CED-1 mutant strains 
MT4930 and MT4933, obtained from the Caenorhabditis Genetics Center 
(CGC) database. In some experiments, we used siRNA to down-regulate 
  C. elegans   scavenger receptor orthologues (Table S2, available at http://www
.jem.org/cgi/content/full/jem.20082109/DC1). For the studies examining 
the potential   C. elegans     SCARB1  ,   SCARB2  , and   CD36   orthologues, we 
used three worm strains from the CGC database: RB1227 (mutant for the 
  Y49E10.20/SCARB1   gene), RB973 (mutant for the   Y76A2B/SCARB2   
gene), and RB1409 (mutant for the   R07B1.3/CD36   gene). The other three 
genes for the remaining   CD36   orthologues (  C03F11.3  ,   F11C1.3  , and 
  F07A5.3  ), for which mutants did not exist, were down-regulated by siRNA 
(Table S2).   C. elegans   strain L4440 was used as the control strain for the 
siRNA experiments, and the N2 strain was used as the control for the mutant 
strains. Each survival experiment was repeated using at least 100 nematodes 
divided in 3 diff  erent plates per strain. Data shown are from a representative 
experiment. Each experiment was repeated three times with similar results. 
  In vivo infections.     For i.v. infections, the mice received 0.1 ml containing 
100,000 yeast cells resuspended in PBS, injected in the lateral tail vein. The ac-
tual number of CFUs administered was confi  rmed using colony plate counts. 
For assessment of lethality, WT and   CD36      /        mice were injected with   C. neo-
formans   and monitored every 12 h for moribund state or death. Moribund ani-
mals were killed by CO  2   asphyxiation. 
    C. neoformans   staining.     7-  μ  m frozen liver sections were fi  xed in 100% 
methanol for 5 min. Staining was performed using a Fungi-Fluor kit (Poly-
sciences) according to the manufacturer  ’  s protocol. Sections were rinsed and 
stained for 30 s in hematoxylin. Sections were mounted using Vectashield 
(Vector Laboratories). Photos were taken at 20  ×   using a camera (DXM 
1200C; Nikon) and AR software (Nis-Elements). 
  Cloning of human   SCARF1   and generation of stable CHO-SCARF1 
cell lines.     Human   SCARF1   was cloned from a human microvascular endo-
thelial cell  –  derived cDNA library in the PEAK-8 vector (Edge Biosystems) us-
ing an expression cloning strategy. In brief, the cDNA library was divided into 
pools of 5,000 individual cDNA clones, and each pool was transfected into 
HEK 293 cells. Cells that bound fl  uorescently labeled acLDL were selected and 
individual clones were identifi  ed (  17  ). One of these clones had 100% homol-
ogy to the published sequence of human   SCARF1   (available from GenBank/
EMBL/DDBJ under accession no.   NM_003693  ). Stably transfected CHO-
SCARF1 and CHO-PURO cells were generated by transfecting SCARF1 
cDNA or the empty PEAK8 vector, and selecting high expressors by culturing 
in 2   μ  g/ml puromycin and carrying out FACS of the surviving cells. 
  Immunofl  uorescence staining.     Anti-SCARF1 rabbit polyclonal antibodies 
were generated against the synthetic peptide RGTQGSELDPKGQHVC 
from the human extracellular domain of SCARF1. CHO or CHO-SCARF1 
infection between WT and Dectin-1 KO mice (  14  ). We con-
fi  rmed these results and found that RAW macrophages silenced 
for Dectin-1 or Dectin-2 did not exhibit a reduction in cyto-
kine induction after stimulation by   C. neoformans.   Our results 
are possibly caused by the low expression of these receptors on 
RAW cells. However, it is likely that CD36 and SCARF1 
rather than Dectin-1 play a more prominent role in cytokine 
production than Dectins in response to fungal pathogens. The 
mannose receptor binds   C. neoformans   through the recognition 
of mannosylated proteins present in the fungal cell wall. After   C. 
neoformans   infection, mannose receptor  –  defi  cient mice died sig-
nifi  cantly faster than WT mice (  54  ). Interestingly, no signifi  cant 
diff  erence in survival between mannose receptor  –  defi  cient and 
WT mice infected with   C. albicans   was observed, and both mice 
exhibited competence in infl  ammatory cell recruitment and an-
tibody production (  55  ). Because SCARF1 appears to bind fun-
gal pathogens in a mannan-dependent manner, it is possible that 
SCARF1 and the mannan receptor play complementary roles in 
innate immunity to   C. albicans  . The role of scavenger receptors 
in innate immunity is only beginning to be uncovered. Our data 
strongly support such a role in response to fungal infections. 
  MATERIALS AND METHODS 
  Reagents.     The extracellular domain of mouse CD36 was cloned into the 
Fc fusion mammalian expression vector pFUSE-IgG1-Fc2 (InvivoGen). 
This plasmid fuses the extracellular scavenger receptor domain to the Fc 
region of IgG and contains the IL-2 signal sequence to allow for the secre-
tion of the Fc fusion proteins. The construct was transfected into HEK 293 
cells and stable high expressing clones were isolated. The Fc fusion protein 
was purifi  ed by a single-step protein G affi   nity chromatography. RAGE-Fc 
fusion protein was purchased from R  &  D Systems. Ultrapure LPS was pur-
chased from InvivoGen. The anti  –  mouse TLR2 and isotype control anti-
bodies were purchased from eBioscience. All carbohydrates were obtained 
from Sigma-Aldrich. 
  Mice.       CD36      /        mice were generated by targeted gene disruption in mouse 
embryonic stem cells by homologous recombination (  56  ).   CD36      /        mice, 
  CD36  +/+     littermate controls, and WT C57BL/6 mice purchased from the 
Jackson Laboratory were used for the in vitro and in vivo experiments. Ani-
mal protocols were reviewed and approved by the Massachusetts General 
Hospital subcommittee on research animal care, and conform to the United 
States Department of Agriculture animal welfare act and the Public Health 
Service policy on the humane care and use of laboratory animals. 
    C. neoformans   and   C. albicans  .     The highly virulent encapsulated   C. neofor-
mans   strain H99 (American Type Culture Collection) and the   C. albicans   
strain (American Type Culture Collection) were grown on yeast-peptone-
dextrose agar (Difco) at 30  °  C. For each infection, a fresh culture of   C. neofor-
mans   or   C. albicans   was started from     80  °  C stocks. For experiments, a fresh 
colony was isolated from an agar plate and grown in YPD media for 24 h at 
30  °  C. Before inoculation, the yeast cells were washed three times in PBS, 
counted, and adjusted to the appropriate concentration.   S. typhimurium   was a 
gift from E. Hohmann (Massachusetts General Hospital, Boston, MA) and 
was propagated in Brain Heart Infusion media (Difco) or plates. 
  shRNA lentiviral infections.     Plasmids encoding lentiviruses expressing 
shRNAs were obtained from the RNAi Consortium library TRC-Mm1.0 (Ta-
ble S1, available at http://www.jem.org/cgi/content/full/jem.20082109/
DC1) (  29  ). Plasmids were purifi  ed using a miniprep kit (QiaPrep; QIAGEN). 
Plasmids were then transfected into HEK 293T cells with a three-plasmid 
system to produce lentivirus. Infection conditions were optimized in 96-well 
plates. 20,000 macrophages were placed in each well of 96-well tissue cul-JEM VOL. 206, March 16, 2009 
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QPCR reaction. Subsequent analysis was performed on the data output from 
the MX4000 software (Agilent Technologies) using Excel 2002 (Microsoft). 
In this study, we modifi  ed a protocol described by Amjad et al. to quantify 
viable   C. neoformans   in the spleen and liver of   C. neoformans    –  infected mice by a 
two-step QPCR amplifi  cation of the capsule (CAP10) gene mRNA (  43  ). The 
forward primer was CAP10F 5    -  TTCTCCTCTCCTGACCGACT-3    ,   and 
the reverse primer was CAP10R 5    -  CTCTTCTTGTACTCGGCAACG-3        .   
In addition, we used QPCR to measure cell activation of TLR2- and CD36-
transfected CHO cells. In preliminary experiments, we found that stimula-
tion of CHO cells induced the activation of NF-    B and mRNA production 
of the neutrophil chemoattractant GRO (available from GenBank/EMBL/
DDBJ under accession no.   J03560  ). The forward primer was CHOGRO1F 
5    -GTGCCTGCAGACCATGACAG-3    , and the reverse primer was 
CHOGRO1R 5    -GACTTCGGTTTGGGTGCAGT-3    . 
  Online supplemental material.     Fig. S1 shows the eff  ects of silencing   CED-1   
on   C. elegans   survival in response to   C. neoformans   infection, and the eff  ects of 
  CED-1   defi  ciency on the survival of   C. elegans   infected with   S. typhimurium   or 
  S. aureus  . Fig. S2 shows the eff  ects of silencing various   C. elegans     CD36   ortho-
logues and defi  ciency in two   SCARB1   orthologues on survival after infection 
with   C. neoformans  . Fig. S3 displays the alignment of   C. elegans     C03F11.1   and 
mouse and human   CD36  . Fig. S4 shows the shRNA knockdown effi   ciency 
and specifi  city for   TLR4  ,   TLR7  , and   TLR9  . Fig. S5 shows that CD36 mediates 
binding of   C. albicans   to macrophages in a     -glucan  –  dependant manner, and 
activation of these cells to produce proinfl  ammatory chemokines and cyto-
kines. Fig. S6 shows that targeted deletion of   CD36   does not aff  ect expression 
of other     -glucan receptors in macrophages. Tables S1 and S2 provide the 
gene identifi  ers and shRNA target sequences for   CD36  ,   TLR2  ,   SCARB2  , 
  SCARF1  , and their   C. elegans   orthologues. Table S3 contains the sequences of 
the QPCR primers used in this study. Online supplemental material is avail-
able at http://www.jem.org/cgi/content/full/jem.20082109/DC1. 
  T.K. Means and J. El Khoury designed and performed experiments, and wrote the 
paper. E. Mylonakis, E. Tampakakis, E. Seung, and R. Pukkila-Worley performed   C. 
elegans   experiments and in vivo   C. neoformans   experiments. L. Puckett performed 
gene expression and binding experiments, S.E. Hickman performed cell isolations 
and generated stable cell lines, and K.J. Moore and C.R. Stewart performed   C. 
neoformans   experiments and provided CD36     /     mice. R.A. Colvin and M.F. Tai 
performed immunohistochemistry and fl  uorescence microscopy. N. Hacohen 
generated and provided the mouse shRNA library and protocols for using the 
library. S.B. Calderwood and A.D. Luster gave valuable suggestions and discussions 
regarding the design of the experiments, and helped edit the manuscript. 
  This work was supported by National Institutes of Health grants AR051367 (to 
T.K. Means), NS059005 and AG032349 (to J. El Khoury), AI63084 and AI075286 (to 
E. Mylonakis), AI71060 (to N. Hacohen), and AG20255 (to K.J. Moore), and an 
Irvington Institute grant (to T.K. Means). 
  The authors have no confl  icting fi  nancial interests. 
Submitted:   23 September 2008 
Accepted:   2 February 2009 
  REFERENCES 
       1  .   Perfect  ,   J.R.  , and   A.     Casadevall  .   2002  .   Cryptococcosis.       Infect. Dis. Clin. 
North Am.       16  :  837    –    874  .    
       2  .   Richardson  ,   M.  , and   C.     Lass-Florl  .   2008  .   Changing epidemiology of 
systemic fungal infections.       Clin. Microbiol. Infect.       14  (  Suppl. 4  ):  5    –    24  .    
       3  .   Netea  ,   M.G.  ,   G.D.     Brown  ,   B.J.     Kullberg  , and   N.A.     Gow  .   2008  .   An 
integrated model of the recognition of   Candida albicans   by the innate 
immune system.       Nat. Rev. Microbiol.       6  :  67    –    78  .    
       4  .   Goldman  ,   D.L.  ,   S.C.     Lee  , and   A.     Casadevall  .   1995  .   Tissue localization 
of   Cryptococcus neoformans   glucuronoxylomannan in the presence and ab-
sence of specifi  c antibody.       Infect. Immun.       63  :  3448    –    3453  .   
       5  .   Levitz  ,  S.M.  ,  A.    Tabuni  ,  H.    Kornfeld  ,  C.C.    Reardon  , and  D.T.    Golenbock  . 
  1994  .   Production of tumor necrosis factor alpha in human leukocytes 
stimulated by   Cryptococcus neoformans  .       Infect. Immun.       62  :  1975    –    1981  .   
       6  .   Vecchiarelli  ,   A.  ,   M.     Dottorini  ,   D.     Pietrella  ,   C.     Monari  ,   C.     Retini  ,   T.   
  Todisco  , and   F.     Bistoni  .   1994  .   Role of human alveolar macrophages 
cells, or mouse peritoneal macrophages were plated on multispot glass slides 
and incubated with anti-SCARF1 or control antibodies for 2 h (1:500 dilu-
tion). FITC- or rhodamine-labeled donkey anti  –  rabbit antibodies were added, 
and the cells were visualized by fl  uorescence microscopy (Eclipse ME600; 
Nikon) and digitally photographed (DXM 1200C camera). Nuclei were 
stained with DAPI (blue). 
  Yeast binding assays.     Yeast cells were labeled with FITC according to 
published protocols (  20  ). FITC-labeled yeast cells were added in serum-free 
medium at an organism/cell ratio of 1:1, 5:1, 10:1, 25:1, or 50:1, and binding 
was allowed to occur for 1  –  2 h at 4  °  C. Unbound yeasts were removed by ex-
tensive washing, and the cells were fi  xed in 2% paraformaldehyde for micros-
copy and digital imaging or detached in divalent cation  –  free buff  er and then 
fi  xed in 2% paraformaldehyde for fl  ow cytometry, or fl  uorescence was mea-
sured in a microplate reader (Fluoroskan Ascent FL; Thermo Fisher Scientifi  c). 
The number of yeast cells that bound to cells was determined as previously de-
scribed (  22, 23, 57  –  59  ). For anti-SCARF1, control antibody, Fc-fusion pro-
teins, or carbohydrate competition experiments, the cells were preincubated 
with these reagents for 30 min, and the yeasts were added for an additional 1  –  2 h. 
Data shown are the means of three determinations from a representative ex-
periment. Each experiment was repeated three times with similar results. Sta-
tistical analysis was performed using one-way analysis of variance provided in 
the Prism 4 graphics and statistics software (GraphPad Software, Inc.). 
  Isolation of primary macrophages and bone marrow  –  derived 
macrophages.     Thioglycollate-elicited peritoneal macrophages were harvested 
from 8  –  12-wk-old CD36      /      and CD36  +/+   mice, as previously described 
(  20  ). Cells were confi  rmed to be   >  95% macrophages by staining with F4/80, 
CD11b, CD11c, and anti-GR1 antibodies. Bone marrow  –  derived macro-
phages were prepared by culturing the bone marrow isolated from the femur 
and tibia of mice in 10 ng/ml M-CSF. On day 4, the cells were washed and 
placed in fresh media with M-CSF. On day 7, the adherent macrophages 
were detached, counted, and passed into the appropriate size dish for in 
vitro experiments. 
  Assessment of   C. neoformans   internalization.     Thioglycollate-elicited peri-
toneal macrophages were harvested as described in the previous section. CHO, 
CHO-SCARF1, WT, or CD36      /      peritoneal macrophages were plated in 
24-well plates at 2   ×   10  5   cells per well in 1 ml DMEM supplemented with 10% 
fetal calf serum and incubated overnight. The cells were washed with PBS, and 
labeled   C. neoformans   were added at 20 CFU per macrophage for 2 h at 37  °  C. 
Phagocytosis was stopped by the addition of cold PBS. The fl  uorescence of 
extracellular yeast was quenched by incubation with PBS containing 1.0 mg/
ml Trypan blue for 10 min at room temperature, as previously described (  20  ). 
Intracellular fl  uorescence of phagocytosed yeast was measured by fl  ow cytom-
etry using a fl  ow cytometer (FACSCalibur; BD). 
  Intracellular cytokine staining.     Macrophages were stimulated for 30 min 
with   C. neoformans  . Next, 1   μ  l/ml GolgiPlug (BD) was added to the culture 
media, and after an additional 5.5 h, the macrophages were harvested and re-
suspended in 4% paraformaldehyde for 10 min, spun down at 450   g  , and resus-
pended in PBS containing 0.1% saponin, anti  –  mouse MIP-1      –  FITC (R  &  D 
Systems), and anti  –  mouse TNF-PE (eBioscience). 30 min later, the cells were 
washed and immediately run on a FACSCalibur. 
  QPCR.     Total RNA was extracted using the RNeasy kit according to the 
manufacturer  ’  s protocol (QIAGEN), and each sample was reverse transcribed 
using multiscribe RT (Applied Biosystems). Oligonucleotide primers were 
designed using Primer Express software (version 1.0; Applied Biosystems) or 
Primer Bank (available at http://pga.mgh.harvard.edu/primerbank/; Table S3, 
available at http://www.jem.org/cgi/content/full/jem.20082109/DC1) (  60  ). 
The 25-  μ  l QPCR reaction contained 2   μ  l of cDNA, 12.5   μ  l of 2  ×   SYBR 
green master mix (Applied Biosystems), and 500 nM of sense and antisense 
primers. A series of standards was prepared by performing 10-fold serial dilu-
tions of full-length cDNAs in the range of 20 million copies to 2 copies per 652 SCAVENGER RECEPTORS AND INNATE IMMUNITY TO FUNGAL INFECTIONS   | Means et al. 
        26  .   Harris  ,   T.W.  ,   R.     Lee  ,   E.     Schwarz  ,   K.     Bradnam  ,   D.     Lawson  ,   W.   
  Chen  ,   D.     Blasier  ,   E.     Kenny  ,   F.     Cunningham  ,   R.     Kishore  ,   et al  .   2003  . 
  WormBase: a cross-species database for comparative genomics.       Nucleic 
Acids Res.       31  :  133    –    137  .    
        27  .   Mallo  ,   G.V.  ,   C.L.     Kurz  ,   C.     Couillault  ,   N.     Pujol  ,   S.     Granjeaud  ,   Y.   
  Kohara  , and   J.J.     Ewbank  .   2002  .   Inducible antibacterial defense system 
in   C. elegans  .       Curr. Biol.       12  :  1209    –    1214  .    
        28  .   Kato  ,   Y.  ,   T.     Aizawa  ,   H.     Hoshino  ,   K.     Kawano  ,   K.     Nitta  , and   H.     Zhang  . 
  2002  .   abf-1 and abf-2, ASABF-type antimicrobial peptide genes in 
  Caenorhabditis elegans  .       Biochem. J.       361  :  221    –    230  .    
        29  .   Moff  at  ,   J.  ,   D.A.     Grueneberg  ,   X.     Yang  ,   S.Y.     Kim  ,   A.M.     Kloepfer  ,   G.   
  Hinkle  ,   B.     Piqani  ,   T.M.     Eisenhaure  ,   B.     Luo  ,   J.K.     Grenier  ,   et al  .   2006  . 
  A lentiviral RNAi library for human and mouse genes applied to an ar-
rayed viral high-content screen.       Cell      .     124  :  1283    –    1298  .    
        30  .   Tamura  ,   Y.  ,   J.     Osuga  ,   H.     Adachi  ,   R.     Tozawa  ,   Y.     Takanezawa  ,   K.   
  Ohashi  ,   N.     Yahagi  ,   M.     Sekiya  ,   H.     Okazaki  ,   S.     Tomita  ,   et al  .   2004  . 
  Scavenger receptor expressed by endothelial cells I (SREC-I) mediates 
the uptake of acetylated low density lipoproteins by macrophages stimu-
lated with lipopolysaccharide.       J. Biol. Chem.       279  :  30938    –    30944  .    
        31  .   Bolanos  ,   B.  , and   T.G.     Mitchell  .   1989  .   Phagocytosis and killing of 
  Cryptococcus neoformans   by rat alveolar macrophages in the absence of 
serum.       J. Leukoc. Biol.       46  :  521    –    528  .   
        32  .   Chang  ,   Y.C.  ,   M.F.     Stins  ,   M.J.     McCaff  ery  ,   G.F.     Miller  ,   D.R.     Pare  ,   T.   
  Dam  ,   M.     Paul-Satyaseela  ,   K.S.     Kim  , and   K.J.     Kwon-Chung  .   2004  . 
  Cryptococcal yeast cells invade the central nervous system via transcellu-
lar penetration of the blood-brain barrier.       Infect. Immun.       72  :  4985    –    4995  .     
        33  .   Rachini  ,   A.  ,   D.     Pietrella  ,   P.     Lupo  ,   A.     Torosantucci  ,   P.     Chiani  ,   C.   
  Bromuro  ,   C.     Proietti  ,   F.     Bistoni  ,   A.     Cassone  , and   A.     Vecchiarelli  .   2007  . 
  An anti-beta-glucan monoclonal antibody inhibits growth and capsule 
formation of   Cryptococcus neoformans   in vitro and exerts therapeutic, anti-
cryptococcal activity in vivo.       Infect. Immun.       75  :  5085    –    5094  .    
        34  .   Torosantucci  ,   A.  ,   C.     Bromuro  ,   P.     Chiani  ,   F.     De Bernardis  ,   F.     Berti  ,   C.   
  Galli  ,   F.     Norelli  ,   C.     Bellucci  ,   L.     Polonelli  ,   P.     Costantino  ,   et al  .   2005  . 
  A novel glyco-conjugate vaccine against fungal pathogens.       J. Exp. Med.     
  202  :  597    –    606  .    
        35  .   Brown  ,   G.D.  , and   S.     Gordon  .   2005  .   Immune recognition of fungal 
beta-glucans.       Cell. Microbiol.       7  :  471    –    479  .    
        36  .   Jeannin  ,   P.  ,   B.     Bottazzi  ,   M.     Sironi  ,   A.     Doni  ,   M.     Rusnati  ,   M.     Presta  ,   V.   
  Maina  ,   G.     Magistrelli  ,   J.F.     Haeuw  ,   G.     Hoeff  el  ,   et al  .   2005  .   Complexity 
and complementarity of outer membrane protein A recognition by cel-
lular and humoral innate immunity receptors.       Immunity      .     22  :  551    –    560  .    
        37  .   Biondo  ,   C.  ,   A.     Midiri  ,   L.     Messina  ,   F.     Tomasello  ,   G.     Garufi    ,   M.R.   
  Catania  ,   M.     Bombaci  ,   C.     Beninati  ,   G.     Teti  , and   G.     Mancuso  .   2005  . 
  MyD88 and TLR2, but not TLR4, are required for host defense against 
  Cryptococcus neoformans  .       Eur. J. Immunol.       35  :  870    –    878  .    
        38  .   Hoebe  ,   K.  ,   P.     Georgel  ,   S.     Rutschmann  ,   X.     Du  ,   S.     Mudd  ,   K.     Crozat  , 
  S.     Sovath  ,   L.     Shamel  ,   T.     Hartung  ,   U.     Zahringer  , and   B.     Beutler  .   2005  . 
  CD36 is a sensor of diacylglycerides.       Nature      .     433  :  523    –    527  .    
        39  .   Triantafi  lou  ,   M.  ,   F.G.     Gamper  ,   R.M.     Haston  ,   M.A.     Mouratis  ,   S.   
  Morath  ,   T.     Hartung  , and   K.     Triantafi  lou  .   2006  .   Membrane sorting of 
toll-like receptor (TLR)-2/6 and TLR2/1 heterodimers at the cell sur-
face determines heterotypic associations with CD36 and intracellular 
targeting.       J. Biol. Chem.       281  :  31002    –    31011  .    
        40  .   Triantafi  lou  ,   M.  ,   F.G.     Gamper  ,   P.M.     Lepper  ,   M.A.     Mouratis  ,   C.   
  Schumann  ,   E.     Harokopakis  ,   R.E.     Schiff  erle  ,   G.     Hajishengallis  , and   K.   
  Triantafi  lou  .   2007  .   Lipopolysaccharides from atherosclerosis-associated 
bacteria antagonize TLR4, induce formation of TLR2/1/CD36 com-
plexes in lipid rafts and trigger TLR2-induced infl  ammatory responses 
in human vascular endothelial cells.       Cell. Microbiol.       9  :  2030    –    2039  .    
      41  .   Toshchakov  ,  V.  ,  B.W.    Jones  ,  P.Y.    Perera  ,  K.    Thomas  ,  M.J.    Cody  ,  S.    Zhang  , 
  B.R.    Williams  ,  J.    Major  ,  T.A.    Hamilton  ,  M.J.    Fenton  , and  S.N.    Vogel  .  2002  . 
  TLR4, but not TLR2, mediates IFN-beta-induced STAT1alpha/beta-de-
pendent gene expression in macrophages.       Nat. Immunol.       3  :  392    –    398  .    
      42  .   Re  ,  F.  , and  J.L.    Strominger  .  2001  .  Toll-like receptor 2 (TLR2) and TLR4 dif-
ferentially activate human dendritic cells.       J. Biol. Chem.       276  :  37692    –    37699  .   
        43  .   Amjad  ,   M.  ,   N.     Kfoury  ,   R.     Cha  , and   R.     Mobarak  .   2004  .   Quantifi  cation 
and assessment of viability of   Cryptococcus neoformans   by LightCycler am-
plifi  cation of capsule gene mRNA.       J. Med. Microbiol.       53  :  1201    –    1206  .    
as antigen-presenting cells in   Cryptococcus neoformans   infection.       Am. J. 
Respir. Cell Mol. Biol.       11  :  130    –    137  .   
       7  .   Santangelo  ,   R.  ,   H.     Zoellner  ,   T.     Sorrell  ,   C.     Wilson  ,   C.     Donald  ,   J.   
  Djordjevic  ,   Y.     Shounan  , and   L.     Wright  .   2004  .   Role of extracellular 
phospholipases and mononuclear phagocytes in dissemination of cryp-
tococcosis in a murine model.       Infect. Immun.       72  :  2229    –    2239  .    
       8  .   Brown  ,   G.D.  , and   S.     Gordon  .   2001  .   Immune recognition. A new re-
ceptor for beta-glucans.       Nature      .     413  :  36    –    37  .    
       9  .   Brown  ,   G.D.  ,   J.     Herre  ,   D.L.     Williams  ,   J.A.     Willment  ,   A.S.     Marshall  , 
and   S.     Gordon  .   2003  .   Dectin-1 mediates the biological eff  ects of     -glu-
cans.       J. Exp. Med.       197  :  1119    –    1124  .    
      10  .   Dennehy  ,   K.M.  , and   G.D.     Brown  .   2007  .   The role of the beta-glucan re-
ceptor Dectin-1 in control of fungal infection.       J. Leukoc. Biol.       82  :  253    –    258  .     
        11  .   Gantner  ,   B.N.  ,   R.M.     Simmons  ,   S.J.     Canavera  ,   S.     Akira  , and   D.M.   
  Underhill  .   2003  .   Collaborative induction of infl  ammatory responses by 
dectin-1 and Toll-like receptor 2.       J. Exp. Med.       197  :  1107    –    1117  .    
        12  .   Goodridge  ,   H.S.  ,   R.M.     Simmons  , and   D.M.     Underhill  .   2007  .   Dectin-1 
stimulation by   Candida albicans   yeast or zymosan triggers NFAT activa-
tion in macrophages and dendritic cells.       J. Immunol.       178  :  3107    –    3115  .   
        13  .   Taylor  ,   P.R.  ,   S.V.     Tsoni  ,   J.A.     Willment  ,   K.M.     Dennehy  ,   M.     Rosas  ,   H.   
  Findon  ,   K.     Haynes  ,   C.     Steele  ,   M.     Botto  ,   S.     Gordon  , and   G.D.     Brown  . 
  2007  .   Dectin-1 is required for beta-glucan recognition and control of 
fungal infection.       Nat. Immunol.       8  :  31    –    38  .    
        14  .   Nakamura  ,   K.  ,   T.     Kinjo  ,   S.     Saijo  ,   A.     Miyazato  ,   Y.     Adachi  ,   N.     Ohno  ,   J.   
  Fujita  ,   M.     Kaku  ,   Y.     Iwakura  , and   K.     Kawakami  .   2007  .   Dectin-1 is not 
required for the host defense to   Cryptococcus neoformans  .       Microbiol. Immunol.     
  51  :  1115    –    1119  .   
        15  .   Saijo  ,   S.  ,   N.     Fujikado  ,   T.     Furuta  ,   S.H.     Chung  ,   H.     Kotaki  ,   K.     Seki  ,   K.   
  Sudo  ,   S.     Akira  ,   Y.     Adachi  ,   N.     Ohno  ,   et al  .   2007  .   Dectin-1 is required 
for host defense against   Pneumocystis carinii   but not against   Candida albicans  .   
    Nat. Immunol.       8  :  39    –    46  .    
      16  .   Coraci  ,   I.S.  ,   J.     Husemann  ,   J.W.     Berman  ,   C.     Hulette  ,   J.H.     Dufour  ,   G.K.   
  Campanella  ,   A.D.     Luster  ,   S.C.     Silverstein  , and   J.B.     El-Khoury  .   2002  . 
  CD36, a class B scavenger receptor, is expressed on microglia in Alzheimer  ’  s 
disease brains and can mediate production of reactive oxygen species in 
response to beta-amyloid fi  brils.       Am. J. Pathol.       160  :  101    –    112  .   
        17  .   El Khoury  ,   J.B.  ,   K.J.     Moore  ,   T.K.     Means  ,   J.     Leung  ,   K.     Terada  ,   M.   
  Toft  ,   M.W.     Freeman  , and   A.D.     Luster  .   2003  .   CD36 mediates the innate 
host response to     -amyloid.       J. Exp. Med.       197  :  1657    –    1666  .    
        18  .   Maxeiner  ,   H.  ,   J.     Husemann  ,   C.A.     Thomas  ,   J.D.     Loike  ,   J.     El Khoury  , 
and   S.C.     Silverstein  .   1998  .   Complementary roles for scavenger receptor 
A and CD36 of human monocyte-derived macrophages in adhesion to 
surfaces coated with oxidized low-density lipoproteins and in secretion 
of H  2  O  2  .       J. Exp. Med.       188  :  2257    –    2265  .    
        19  .   Stuart  ,   L.M.  ,   J.     Deng  ,   J.M.     Silver  ,   K.     Takahashi  ,   A.A.     Tseng  ,   E.J.   
  Hennessy  ,   R.A.     Ezekowitz  , and   K.J.     Moore  .   2005  .   Response to 
  Staphylococcus aureus   requires CD36-mediated phagocytosis triggered by 
the COOH-terminal cytoplasmic domain.       J. Cell Biol.       170  :  477    –    485  .    
      20  .   Thomas  ,   C.A.  ,   Y.     Li  ,   T.     Kodama  ,   H.     Suzuki  ,   S.C.     Silverstein  , and   J.     El 
Khoury  .  2000  .  Protection from lethal gram-positive infection by macrophage 
scavenger receptor  –  dependent phagocytosis.       J. Exp. Med.       191  :  147    –    156  .    
        21  .   Suzuki  ,   H.  ,   Y.     Kurihara  ,   M.     Takeya  ,   N.     Kamada  ,   M.     Kataoka  ,   K.   
  Jishage  ,   O.     Ueda  ,   H.     Sakaguchi  ,   T.     Higashi  ,   T.     Suzuki  ,   et al  .   1997  .   A 
role for macrophage scavenger receptors in atherosclerosis and suscepti-
bility to infection.       Nature      .     386  :  292    –    296  .    
      22  .   Mylonakis  ,  E.  ,  F.M.    Ausubel  ,  J.R.    Perfect  ,  J.    Heitman  , and  S.B.    Calderwood  . 
  2002  .   Killing of   Caenorhabditis elegans   by   Cryptococcus neoformans   as a model 
of yeast pathogenesis.       Proc. Natl. Acad. Sci. USA      .     99  :  15675    –    15680  .    
        23  .   Mylonakis  ,   E.  ,   A.     Idnurm  ,   R.     Moreno  ,   J.     El Khoury  ,   J.B.     Rottman  ,   F.M.   
  Ausubel  ,   J.     Heitman  , and   S.B.     Calderwood  .   2004  .     Cryptococcus neoformans   
Kin1 protein kinase homologue, identifi  ed through a   Caenorhabditis ele-
gans   screen, promotes virulence in mammals.       Mol. Microbiol.       54  :  407    –    419  .     
        24  .   Zhou  ,   Z.  ,   E.     Hartwieg  , and   H.R.     Horvitz  .   2001  .   CED-1 is a trans-
membrane receptor that mediates cell corpse engulfment in   C. elegans  .   
    Cell      .     104  :  43    –    56  .    
        25  .   Altschul  ,   S.F.  ,   T.L.     Madden  ,   A.A.     Schaff  er  ,   J.     Zhang  ,   Z.     Zhang  ,   W.   
  Miller  , and   D.J.     Lipman  .   1997  .   Gapped BLAST and PSI-BLAST: a 
new generation of protein database search programs.       Nucleic Acids Res.     
  25  :  3389    –    3402  .    JEM VOL. 206, March 16, 2009 
ARTICLE
653
        44  .   Haskins  ,   K.A.  ,   J.F.     Russell  ,   N.     Gaddis  ,   H.K.     Dressman  , and   A.     Aballay  . 
  2008  .   Unfolded protein response genes regulated by CED-1 are re-
quired for   Caenorhabditis elegans   innate immunity.       Dev. Cell      .     15  :  87    –    97  .   
        45  .   Rice  ,   P.J.  ,   J.L.     Kelley  ,   G.     Kogan  ,   H.E.     Ensley  ,   J.H.     Kalbfl  eisch  ,   I.W.   
  Browder  , and   D.L.     Williams  .   2002  .   Human monocyte scavenger re-
ceptors are pattern recognition receptors for (1  →  3)-beta-D-glucans.   
    J. Leukoc. Biol.       72  :  140    –    146  .   
      46  .   Cross  ,   C.E.  , and   G.J.     Bancroft  .   1995  .   Ingestion of acapsular   Cryptococcus 
neoformans   occurs via mannose and beta-glucan receptors, resulting in cyto-
kine production and increased phagocytosis of the encapsulated form.       Infect. 
Immun.       63  :  2604    –    2611  .   
        47  .   Mansour  ,   M.K.  ,   E.     Latz  , and   S.M.     Levitz  .   2006  .     Cryptococcus neoformans   
glycoantigens are captured by multiple lectin receptors and presented by 
dendritic cells.       J. Immunol.       176  :  3053    –    3061  .   
        48  .   Yauch  ,   L.E.  ,   M.K.     Mansour  , and   S.M.     Levitz  .   2005  .   Receptor-medi-
ated clearance of   Cryptococcus neoformans   capsular polysaccharide in vivo.   
    Infect. Immun.       73  :  8429    –    8432  .    
        49  .   Yauch  ,   L.E.  ,   M.K.     Mansour  ,   S.     Shoham  ,   J.B.     Rottman  , and   S.M.     Levitz  . 
  2004  .   Involvement of CD14, toll-like receptors 2 and 4, and MyD88 in 
the host response to the fungal pathogen   Cryptococcus neoformans   in vivo.   
    Infect. Immun.       72  :  5373    –    5382  .    
        50  .   Netea  ,  M.G.  ,  F.    van de Veerdonk ,  I.    Verschueren  ,  J.W.    van der Meer , and 
  B.J.     Kullberg  .   2008  .   Role of TLR1 and TLR6 in the host defense against 
disseminated candidiasis.       FEMS Immunol. Med. Microbiol.       52  :  118    –    123  .   
      51  .   Bellocchio  ,   S.  ,   C.     Montagnoli  ,   S.     Bozza  ,   R.     Gaziano  ,   G.     Rossi  ,   S.S.   
  Mambula  ,  A.    Vecchi  ,  A.    Mantovani  ,  S.M.    Levitz  , and  L.    Romani  .  2004  .  The 
contribution of the Toll-like/IL-1 receptor superfamily to innate and adap-
tive immunity to fungal pathogens in vivo.       J. Immunol.       172  :  3059    –    3069  .   
      52  .   Wells  ,   C.A.  ,   J.A.     Salvage-Jones  ,   X.     Li  ,   K.     Hitchens  ,   S.     Butcher  ,   R.Z.   
  Murray  ,   A.G.     Beckhouse  ,   Y.L.     Lo  ,   S.     Manzanero  ,   C.     Cobbold  ,   et al  .   2008  . 
  The macrophage-inducible C-type lectin, mincle, is an essential com-
ponent of the innate immune response to   Candida albicans  .       J. Immunol.     
  180  :  7404    –    7413  .   
        53  .   Jouault  ,   T.  ,   M.     El Abed-El Behi  ,   M.     Martinez-Esparza  ,   L.     Breuilh  ,   P.A.   
  Trinel  ,   M.     Chamaillard  ,   F.     Trottein  , and   D.     Poulain  .   2006  .   Specifi  c 
recognition of   Candida albicans   by macrophages requires galectin-3 to 
discriminate   Saccharomyces cerevisiae   and needs association with TLR2 for 
signaling.       J. Immunol.       177  :  4679    –    4687  .   
        54  .   Dan  ,   J.M.  ,   R.M.     Kelly  ,   C.K.     Lee  , and   S.M.     Levitz  .   2008  .   Role of the 
mannose receptor in a murine model of   Cryptococcus neoformans   infec-
tion.       Infect. Immun.       76  :  2362    –    2367  .    
        55  .   Lee  ,   S.J.  ,   N.Y.     Zheng  ,   M.     Clavijo  , and   M.C.     Nussenzweig  .   2003  . 
  Normal host defense during systemic candidiasis in mannose receptor-
defi  cient mice.       Infect. Immun.       71  :  437    –    445  .    
        56  .   Moore  ,   K.J.  ,   J.     El Khoury  ,   L.A.     Medeiros  ,   K.     Terada  ,   C.     Geula  ,   A.D.   
  Luster  , and   M.W.     Freeman  .   2002  .   A CD36-initiated signaling cas-
cade mediates infl  ammatory  eff   ects of beta-amyloid.       J. Biol. Chem.     
  277  :  47373    –    47379  .    
        57  .   Aballay  ,   A.  ,   P.     Yorgey  , and   F.M.     Ausubel  .   2000  .     Salmonella typhimurium   
proliferates and establishes a persistent infection in the intestine of 
  Caenorhabditis elegans  .       Curr. Biol.       10  :  1539    –    1542  .    
      58  .   Begun  ,   J.  ,   C.D.     Sifri  ,   S.     Goldman  ,   S.B.     Calderwood  , and   F.M.     Ausubel  . 
  2005  .     Staphylococcus aureus   virulence factors identifi   ed by using a high-
throughput   Caenorhabditis elegans  -killing model.       Infect. Immun.       73  :  872    –    877  .     
        59  .   Garsin  ,   D.A.  ,   C.D.     Sifri  ,   E.     Mylonakis  ,   X.     Qin  ,   K.V.     Singh  ,   B.E.   
  Murray  ,   S.B.     Calderwood  , and   F.M.     Ausubel  .   2001  .   A simple model 
host for identifying Gram-positive virulence factors.       Proc. Natl. Acad. 
Sci. USA      .     98  :  10892    –    10897  .    
        60  .   Wang  ,   X.  , and   B.     Seed  .   2003  .   A PCR primer bank for quantitative gene 
expression analysis.       Nucleic Acids Res.       31  :  e154  .                      